Flavonol

Flavonol

SCHEMBL1278210

O=c1c(O)c(-c2ccccc2)oc2ccccc12.O=c1c(O[C@@H]2O[C@H]([C@H](O)CO)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 6/20 0.61
L3MBTL1 Q9Y468 3/20 0.61
KDM4E B2RXH2 7/20 0.60
P4HB P07237 7/20 0.60
GAA P10253 6/20 0.60
EPHX2 P34913 5/20 0.60
POLB P06746 5/20 0.60
MAPT P10636 5/20 0.60
MAOA P21397 4/20 0.60
XDH P47989 4/20 0.60
SLCO2B1 O94956 3/20 0.60
CA12 O43570 3/20 0.60
CA2 P00918 3/20 0.60
CA4 P22748 3/20 0.60
CA7 P43166 3/20 0.60
ALPI P09923 2/20 0.60
LMNA P02545 2/20 0.60
ADRA2C P18825 2/20 0.60
KDM1A O60341 2/20 0.60
HMGB1 P09429 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quercetin SCHEMBL5953872 0.92 AKR1B1 (0.70) AKR1B1L3MBTL1KDM4EP4HBGAA
SCHEMBL30772268 0.90 AKR1B1 (0.74) AKR1B1L3MBTL1KDM4EP4HBGAA
SCHEMBL24608 0.90 AKR1B1 (0.74) AKR1B1L3MBTL1KDM4EP4HBGAA
SCHEMBL21408655 0.90 AKR1B1 (0.74) AKR1B1L3MBTL1KDM4EP4HBGAA
Water SCHEMBL21836718 0.89 AKR1B1 (0.73) AKR1B1L3MBTL1KDM4EP4HBGAA
Acetone SCHEMBL11411008 0.87 AKR1B1 (0.70) AKR1B1L3MBTL1KDM4EP4HBGAA
Quercitrin SCHEMBL7920286 0.86 P4HB (0.80) AKR1B1L3MBTL1KDM4EP4HBGAA
Quercitrin SCHEMBL17628743 0.85 P4HB (0.81) AKR1B1L3MBTL1KDM4EP4HBGAA
Reynoutrin SCHEMBL2284762 0.83 KDM4E (0.59) AKR1B1L3MBTL1KDM4EP4HBGAA
Rutin SCHEMBL725793 0.81 KDM4E (0.82) AKR1B1L3MBTL1KDM4EP4HBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2624816-A2 STIMULATION OF NEUROREGENERATION BY FLAVONOID GLYCOSIDES Zenobi-Wong, Marcy (CH) 2013-08-14 EP disclosed
US-20120087980-A1 STIMULATION OF NEUROREGENERATION BY FLAVONOID GLYCOSIDES ZENOBI-WONG MARCY (CH) 2012-04-12 US disclosed
WO-2012047763-A2 STIMULATION OF NEUROREGENERATION BY FLAVONOID GLYCOSIDES ZENOBI-WONG MARCY (CH) 2012-04-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120087980-A1 STIMULATION OF NEUROREGENERATION BY FLAVONOID GLYCOSIDES GAP43, BDNF, NGF AKR1B1 3495/4885L3MBTL1 4419/4885KDM4E 4730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.